New extended p-donors combining the tetrathiafulvalene (TTF) system with the conjugated backbone of substituted terthienyls are described.
No takes yet. Share an insight, caveat, or question.
Roncali et al. (1993) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: